Table 1. Summary of main fat grafting concerns and important contributing publications.
Major concerns | Important papers | Publishing journal | Year Published |
---|---|---|---|
Processing, delivery, and storage of fat grafts | Chajchir and Benzaquen 9 | Plastic and Reconstructive Surgery | 1989 |
Coleman
11
Butterwick et al 22 |
Aesthetic Plastic Surgery
Dermatologic Surgery |
1995 2006 |
|
Khouri and Khouri 21 | Plastic and Reconstructive Surgery | 2017 | |
Krastev et al 26 | JAMA Facial Plastic Surgery | 2018 | |
Fat transfer in facial surgery | Krastev et al 26 | JAMA Facial Plastic Surgery | 2018 |
Oncological potential of ADSCs | ASPRS Ad-Hoc Committee on New Procedures 8 | Plastic Surgical Nursing | 1987 |
Zuk et al 13 | Molecular Biology of the Cell | 2002 | |
Gutowski et al 16 | Plastic and Reconstructive Surgery | 2009 | |
Rigotti et al 33 | Aesthetic Plastic Surgery | 2010 | |
Kronowitz et al 34 | Plastic and Reconstructive Surgery | 2016 | |
Interference with cancer screenings | ASPRS Ad-Hoc Committee on New Procedures 8 | Plastic Surgical Nursing | 1987 |
Kneeshaw et al 38 | Breast | 2006 | |
Gutowski et al 16 | Plastic and Reconstructive Surgery | 2009 | |
FDA perspective | Zuk et al 13 | Molecular Biology of the Cell | 2002 |
U.S. Department of Health and Human Services; U.S. Food and Drug Administration 41 | – | 2014 | |
Johnson et al 42 | Aesthetic Plastic Surgery | 2017 | |
U.S. Department of Health and Human Services; U.S. Food and Drug Administration 43 44 | – | 2017 |
Abbreviations: ADSCs, adipose-derived stem cells; ASPRS, American Society of Plastic and Reconstructive Surgeons; FDA, U.S. Food and Drug Administration; JAMA, Journal of the American Medical Association.